Delivery Order V797D70134-75A50325F80013
Award Date
6/30/25
Potential Completion Date
6/29/27
Potential Value
$228M
Awardee
Alvogen, Inc.
Ultimate Awardee
Not listed
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Pine Brook, Montville, NJ 07058, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
3
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Department of Health and Human Services (HHS) Office of the Assistant Secretary for Preparedness and Response (ASPR) awarded a $57,099,989.22 Delivery Order to Alvogen, Inc., a for-profit manufacturer, to provide Oseltamivir Phosphate 75mg, 10 ct Blister (Adult Course). This Delivery Order is part of a larger $505 million single award Indefinite Delivery Contract with Alvogen to deliver the antiviral medication to the Strategic National Stockpile through August 2024. The contract has no...
This is a $1,417.10 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of oseltamivir phosphate 75 mg capsules, which are used to treat influenza. The delivery order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a vehicle for...
This is a federal contract awarded by the Office of the Assistant Secretary for Preparedness and Response, a civilian agency, to Roche Laboratories Inc. for the purchase of Tamiflu® (antiviral medication) for the Strategic National Stockpile. The contract is a definitive contract with a firm fixed price of $199,048,013.60 and does not have a set-aside designation. The contract was awarded on September 30, 2009 with a period of performance ending on September 29, 2011. Roche Laboratories Inc....
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,566,307,107 units of the antiviral medication Oseltamivir Phosphate 75 mg capsules. The $5,284.09 firm-fixed-price contract has a completion date of November 4, 2024 and is not designated as a set-aside. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,566,923,335 units of the antiviral medication Oseltamivir Phosphate 75 mg capsules. The fixed-price delivery order contract, valued at $1,877.00, has a performance period through January 15, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a large Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award is a delivery order valued at $1,494.60 placed by the Defense Logistics Agency (DLA) with AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The award is for the supply of 4,563,471,961 units of the drug Oseltamivir Phosphate 75 mg capsules, an antiviral medication used to treat and prevent influenza. The contract has an ultimate completion date of January 30, 2024 and was awarded on January 29, 2024. It is a firm fixed-price contract with no set-aside...
This federal contract award is for the delivery of Oseltamivir Phosphate 75 mg capsules to the U.S. government. The contract was awarded by the Medical Supply Chain division of the Defense Logistics Agency (DLA), a combat support agency of the Department of Defense (DoD). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distribution company that provides a wide range of medical products and supplies to federal agencies, particularly the DoD and Department of Veterans...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $3,554.79 firm fixed-price delivery order contract is for the supply of 4,567,282,823 units of 30 mg Oseltamivir Phosphate capsules. The contract has a ceiling value of $3,554.79 and runs through February 18, 2025. This award is part of AmerisourceBergen's larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
The Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response has awarded Genentech USA, Inc. a $397 million firm fixed price delivery order contract to supply Tamiflu 75mg capsules (NDC 0004-0800-85) and Tamiflu 30mg capsules (NDC 0004-0802-85) from November 2023 through November 2025. The place of performance will be Genentech's facility located in South San Francisco, California. No subcontractors or set aside designations were identified. This...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,563,449,252 units of the pharmaceutical drug Oseltamivir Phosphate 75 mg capsules. The $1,022.92 order has a completion date of January 26, 2024. Amerisourcebergen Drug Corp, a for-profit organization, serves as a prime contractor providing a range of pharmaceutical products and medical supplies to the Department of...